Published in
Elsevier, Clinical Lymphoma, Myeloma and Leukemia, 1(22), p. 24-33, 2022
DOI: 10.1016/j.clml.2021.07.017
Links
Tools
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes
Journal article published in 2022 by
Rene-Olivier Casasnovas 
,
George Follows,
Josee M. Zijlstra,
Joost S. P. Vermaat ,
Nagesh Kalakonda,
Sylvain Choquet,
Eric Van Den Neste,
Brian Hill,
Catherine Thieblemont,
Federica Cavallo,
Fatima De la Cruz,
John Kuruvilla,
Nada Hamad ,
Ulrich Jaeger,
Paolo F. Caimi
and other authors.
,
George Follows,
Josee M. Zijlstra,
Joost S. P. Vermaat ,
Nagesh Kalakonda,
Sylvain Choquet,
Eric Van Den Neste,
Brian Hill,
Catherine Thieblemont,
Federica Cavallo,
Fatima De la Cruz,
John Kuruvilla,
Nada Hamad ,
Ulrich Jaeger,
Paolo F. Caimi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 